https://www.hcplive.com/view/guillain-barr-syndrome-linked-to-ad26-cov2-s-covid-19-vaccine
The mRNA vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) showed no risk of Guillain-Barré syndrome post-vaccination.
Create an account or login to join the discussion